These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12359126)

  • 1. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits.
    Geromel V; Darin N; Chrétien D; Bénit P; DeLonlay P; Rötig A; Munnich A; Rustin P
    Mol Genet Metab; 2002; 77(1-2):21-30. PubMed ID: 12359126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients.
    Artuch R; Aracil A; Mas A; Monrós E; Vilaseca MA; Pineda M
    Neuropediatrics; 2004 Apr; 35(2):95-8. PubMed ID: 15127307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
    Cooper JM; Schapira AH
    Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects.
    Giorgio V; Schiavone M; Galber C; Carini M; Da Ros T; Petronilli V; Argenton F; Carelli V; Acosta Lopez MJ; Salviati L; Prato M; Bernardi P
    Biochim Biophys Acta Bioenerg; 2018 Sep; 1859(9):901-908. PubMed ID: 29694828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues.
    Orsucci D; Mancuso M; Ienco EC; LoGerfo A; Siciliano G
    Curr Med Chem; 2011; 18(26):4053-64. PubMed ID: 21824087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.
    Duberley KE; Heales SJ; Abramov AY; Chalasani A; Land JM; Rahman S; Hargreaves IP
    Int J Biochem Cell Biol; 2014 May; 50():60-3. PubMed ID: 24534273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone.
    Lerman-Sagie T; Rustin P; Lev D; Yanoov M; Leshinsky-Silver E; Sagie A; Ben-Gal T; Munnich A
    J Inherit Metab Dis; 2001 Feb; 24(1):28-34. PubMed ID: 11286379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
    Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Rustin P; Bonnet D; Rötig A; Munnich A; Sidi D
    Neurology; 2004 Feb; 62(3):524-5; author reply 525; discussion 525. PubMed ID: 14872056
    [No Abstract]   [Full Text] [Related]  

  • 10. Friedreich's ataxia: coenzyme Q10 and vitamin E therapy.
    Cooper JM; Schapira AH
    Mitochondrion; 2007 Jun; 7 Suppl():S127-35. PubMed ID: 17485244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q biosynthesis in health and disease.
    Acosta MJ; Vazquez Fonseca L; Desbats MA; Cerqua C; Zordan R; Trevisson E; Salviati L
    Biochim Biophys Acta; 2016 Aug; 1857(8):1079-1085. PubMed ID: 27060254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 as a therapy for mitochondrial disease.
    Hargreaves IP
    Int J Biochem Cell Biol; 2014 Apr; 49():105-11. PubMed ID: 24495877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial respiratory chain dysfunction caused by coenzyme Q deficiency.
    Rustin P; Munnich A; Rötig A
    Methods Enzymol; 2004; 382():81-8. PubMed ID: 15047097
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants.
    Jauslin ML; Meier T; Smith RA; Murphy MP
    FASEB J; 2003 Oct; 17(13):1972-4. PubMed ID: 12923074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of coenzyme Q10 in neurological disorders.
    Shults CW; Haas R
    Biofactors; 2005; 25(1-4):117-26. PubMed ID: 16873936
    [No Abstract]   [Full Text] [Related]  

  • 17. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.
    Hart PE; Lodi R; Rajagopalan B; Bradley JL; Crilley JG; Turner C; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
    Arch Neurol; 2005 Apr; 62(4):621-6. PubMed ID: 15824263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions.
    Pallotti F; Bergamini C; Lamperti C; Fato R
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ubiquinone: metabolism and functions. Ubiquinone deficiency and its implication in mitochondrial encephalopathies. Treatment with ubiquinone].
    Artuch R; Colomé C; Vilaseca MA; Pineda M; Campistol J
    Rev Neurol; 1999 Jul 1-15; 29(1):59-63. PubMed ID: 10528314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idebenone in patients with Friedreich ataxia.
    Schöls L; Vorgerd M; Schillings M; Skipka G; Zange J
    Neurosci Lett; 2001 Jun; 306(3):169-72. PubMed ID: 11406322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.